Login to Your Account



The Future Looks Promising

Antibodies Could Prove Key To Preventing Migraine

By Peter Winter
Editor

Monday, July 23, 2012

Migraine headaches affect millions of individuals worldwide with an estimated 30 million migraine sufferers in the U.S. alone. Despite that high prevalence only a limited number of effective treatment options for migraine currently exist, which include nonsteroidal anti-inflammatory drugs (NSAIDs) and triptans (5-HTIB/1D agonists).

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription